L. Roy Papp & Associates’s QuidelOrtho QDEL Stock Holding History

L. Roy Papp & Associates’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,500	Closed	-$281K	–	178
2022 Q1	$281K	Sell	2,500 -200	-7%	-$21.3K	0.04%	154
2021 Q4	$364K	Hold	2,700	–	–	0.04%	150
2021 Q3	$381K	Hold	2,700	–	–	0.05%	144
2021 Q2	$346K	Hold	2,700	–	–	0.04%	149
2021 Q1	$345K	Buy	+2,700	New	+$499K	0.05%	145

Other funds holding QDEL

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

L. Roy Papp & Associates's QDEL Position: Q2 2022 in Review

L. Roy Papp & Associates sold out of QuidelOrtho (QDEL) in Q2 2022, closing a stake of 2,500 shares — an estimated $281K sold.

L. Roy Papp & Associates first reported a position in QDEL in Q1 2021 and held it in 5 quarters. The position peaked at $381K in Q3 2021. 347 funds tracked by Wall St. Rank hold QDEL as of Q2 2022.

L. Roy Papp & Associates reported no remaining QuidelOrtho position as of Q2 2022 after selling out during the quarter.
L. Roy Papp & Associates sold 2,500 QuidelOrtho shares in Q2 2022, an estimated $281K.
L. Roy Papp & Associates first reported a position in QuidelOrtho in Q1 2021 and held it in 5 quarters.
L. Roy Papp & Associates's QuidelOrtho position peaked at $381K in Q3 2021.
347 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2022.

Based on L. Roy Papp & Associates's 13F filing for Q2 2022, filed 2 Aug 2022.